Mylan Generic Treads On AstraZeneca Patents, Fed. Circ. Hears
Drugmaker AstraZeneca LP told the Federal Circuit on Thursday that a Delaware federal court had erred when it determined Mylan Pharmaceuticals Inc.'s generic version of Crohn's disease treatment Entocort EC didn't...To view the full article, register now.
Already a subscriber? Click here to view full article